Conformational Dynamics of Sclerostin-LRP6 Complex Analyzed by HDX-MS
Open Access
- 1 September 2021
- journal article
- research article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 29 (5), 527-535
- https://doi.org/10.4062/biomolther.2020.234
Abstract
Sclerostin (SOST), a regulator of bone formation in osteocytes, inhibits the canonical Wnt signaling by interacting with low-density lipoprotein receptor-related protein 5/6 (LRP5/6) to prevent Wnt binding. Loss-of-function mutations of the SOST gene caused massive bone outgrowth and SOST-null mouse exhibited a high bone density phenotype. Therefore, SOST has been suggested as a promising therapeutic target for osteoporosis. A few previous studies with X-ray crystallography identified the binding interfaces between LRP6 and SOST, but there are limitations in these studies as they used truncated SOST protein or SOST peptide. Here, we analyzed the conformational dynamics of SOST-LRP6 E1E2 complex using hydrogen/deuterium exchange mass spectrometry (HDX-MS). We examined the effect of the C-terminal tail of SOST on LRP6 conformation upon complex formation. HDXMS analysis suggested a new potential binding interface for the C-terminal region of SOST that was missing from the previous crystal structure of the SOST-LRP6 E1E2 complex.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2018R1A2B6001554, NRF-2019R1A5A2027340, NRF-2020R1A2C2003783)
This publication has 20 references indexed in Scilit:
- Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding to LRP5/6Developmental Cell, 2011
- Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6Structure, 2011
- Crystal structures of the extracellular domain of LRP6 and its complex with DKK1Nature Structural & Molecular Biology, 2011
- Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosisExpert Opinion on Biological Therapy, 2010
- Reconstitution of a Frizzled8·Wnt3a·LRP6 Signaling Complex Reveals Multiple Wnt and Dkk1 Binding Sites on LRP6Journal of Biological Chemistry, 2010
- Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP SignalsOnline Journal of Public Health Informatics, 2009
- Characterization of the Structural Features and Interactions of SclerostinOnline Journal of Public Health Informatics, 2009
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone StrengthJournal of Bone and Mineral Research, 2008
- SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling InhibitorOnline Journal of Public Health Informatics, 2005
- Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)Human Molecular Genetics, 2001